APA (7th ed.) Citation

D, K., M, H., A, A., AK, S., ZA, R., AA, T., & MA, S. (2024). Ozanimod-mediated remission in experimental autoimmune encephalomyelitis is associated with enhanced activity of CNS CD27low/- NK cell subset. Frontiers in immunology, 15, 1230735. https://doi.org/10.3389/fimmu.2024.1230735

Chicago Style (17th ed.) Citation

D, Kamyan, Hassane M, Alnaqbi A, Souid AK, Rasbi ZA, Tahrawi AA, and Shamsi MA. "Ozanimod-mediated Remission in Experimental Autoimmune Encephalomyelitis Is Associated with Enhanced Activity of CNS CD27low/- NK Cell Subset." Frontiers in Immunology 15 (2024): 1230735. https://doi.org/10.3389/fimmu.2024.1230735.

MLA (9th ed.) Citation

D, Kamyan, et al. "Ozanimod-mediated Remission in Experimental Autoimmune Encephalomyelitis Is Associated with Enhanced Activity of CNS CD27low/- NK Cell Subset." Frontiers in Immunology, vol. 15, 2024, p. 1230735, https://doi.org/10.3389/fimmu.2024.1230735.